Târtea, G.; Popa-Wagner, A.; Sfredel, V.; Mitran, S.I.; Dan, A.O.; Țucă, A.-M.; Preda, A.N.; Raicea, V.; Țieranu, E.; Cozma, D.;
et al. Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model. Int. J. Mol. Sci. 2024, 25, 2118.
https://doi.org/10.3390/ijms25042118
AMA Style
Târtea G, Popa-Wagner A, Sfredel V, Mitran SI, Dan AO, Țucă A-M, Preda AN, Raicea V, Țieranu E, Cozma D,
et al. Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model. International Journal of Molecular Sciences. 2024; 25(4):2118.
https://doi.org/10.3390/ijms25042118
Chicago/Turabian Style
Târtea, Georgică, Aurel Popa-Wagner, Veronica Sfredel, Smaranda Ioana Mitran, Alexandra Oltea Dan, Anca-Maria Țucă, Alexandra Nicoleta Preda, Victor Raicea, Eugen Țieranu, Dragoș Cozma,
and et al. 2024. "Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model" International Journal of Molecular Sciences 25, no. 4: 2118.
https://doi.org/10.3390/ijms25042118
APA Style
Târtea, G., Popa-Wagner, A., Sfredel, V., Mitran, S. I., Dan, A. O., Țucă, A. -M., Preda, A. N., Raicea, V., Țieranu, E., Cozma, D., & Vătășescu, R.
(2024). Chitosan Versus Dapagliflozin in a Diabetic Cardiomyopathy Mouse Model. International Journal of Molecular Sciences, 25(4), 2118.
https://doi.org/10.3390/ijms25042118